Why the study?
Despite effective interventional treatments, acute STEMI mortality remains high, and the relationship between the platelet-to-hemoglobin ratio and in-hospital mortality in STEMI needed investigation.
Does an elevated platelet-to-hemoglobin ratio predict in-hospital mortality in patients with STEMI undergoing coronary intervention?
Does an elevated platelet-to-hemoglobin ratio predict in-hospital mortality in patients with STEMI undergoing coronary intervention?
Answers are grounded in this paper and cite their sources.
An elevated platelet-to-hemoglobin ratio (≥ 1.99) is an independent predictor of in-hospital mortality in patients with STEMI undergoing coronary intervention.
BACKGROUND: Despite effective interventional treatments, the mortality of acute ST-segment elevation myocardial infarction (STEMI) is still high. Several mortality predictors are known in STEMI. Platelet-to-hemoglobin ratio (PHR) is a recently used mortality parameter in cardiac or non-cardiac diseases. We aim to investigate the relationship of PHR with in-hospital mortality in patients with STEMI. METHODS: Eight hundred eighty-four patients were included in the study. All of them underwent coronary intervention due to STEMI. Demographic characteristics, laboratory, electrocardiographic and echocardiographic parameters were analyzed from hospital records. A cut-off value for PHR was determined using receiver operating characteristic (ROC) curve analysis. Then, patients were divided into two groups PHR < 1.99 and PHR ≥ 1.99. The data of both groups were compared. RESULTS: The median age of the study population was 64 (54-75). Of these 633 (71.6 %) were male and 251 (28.4 %) were female. All cause mortality of the study population was 9.7% (n=86). In multivariable logistic regression analysis, PHR was independently associated with a significantly increased risk of in-hospital mortality for STEMI (OR: 2.645, CI: 1.641-4.263, p< 0.001). Also, age (OR: 1.044, CI: 1.021-1.067, p< 0.001), mean arterial pressure (MAP) less than 87 mmHg (OR: 2.078, CI: 1.185-3.645, p= 0.011), prior coronary artery disease (CAD) (OR: 2.839, CI: 1.345-5.993, p= 0.006), anterior myocardial infarction (MI) (OR: 1.912, CI: 1.069-3.421, p= 0.029), creatinine (OR: 3.710, CI: 2.255-6.106, p<0.001), alanine transaminase (ALT) (OR: 1.004, CI: 1.001-1.007, p=0.002), and neutrophil-to-lymphocyte ratio (NLR) (OR: 1.122, CI: 1.014-1.242, p= 0.025) were determined as independent predictors of in-hospital mortality. CONCLUSION: In conclusion, we found that PHR is an independent predictor of in-hospital mortality in patients with STEMI.
No takes yet. Share an insight, caveat, or question.
Işık et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: